Implicating PARP and NAD+ depletion in type I diabetes

Why pancreatic islets should be regarded and regulated like organs.

CellR4-- repair, replacement, regeneration, & reprogramming·2021

Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies.

Diabetes, obesity & metabolism·2014

Novel insight into glucagon receptor action: lessons from knockout and transgenic mouse models.

Diabetes, obesity & metabolism·2011

Estimating number and volume of islets transplanted within a planar immunobarrier diffusion chamber.

Methods in molecular medicine·2011

Rat neonatal beta cells lack the specialised metabolic phenotype of mature beta cells.

Diabetologia·2011

Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells.

Diabetologia·2010

First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.

Nature medicine·2026

Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

Nature medicine·2026

Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

Nature medicine·2026

Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.

Nature medicine·2026

Type 2 diabetes prevention across the life course.

Nature medicine·2026

Large-scale whole-genome sequencing reveals the landscape and health implications of de novo mutations.

Nature medicine·2026

The Role of IGF-1 and IL-10 in Childhood Stunting: Evidence From Indonesia.

TheScientificWorldJournal·2026

Role of glucagon in metabolic diseases.

Journal of diabetes investigation·2026

Are sustainable plant-based diets suitable for all? A nutrigenetic perspective.

Nutrition and health·2026

Systematic Screening of Tryptophan Metabolism Identifies Site- and Microbiota-Dependent Signatures of Tryptophan Utilization in Experimental Colitis.

International journal of tryptophan research : IJTR·2026

Therapeutic potential and research progress of microecological agents in kidney diseases.

Frontiers in medicine·2026

Gut microbiota-immune crosstalk in childhood and adolescent obesity: mechanistic insights and therapeutic potential focused on short-chain fatty acids and emerging metabolites.

Frontiers in microbiology·2026

Related Experiment Videos

Implicating PARP and NAD+ depletion in type I diabetes

Related Concept Videos

Why pancreatic islets should be regarded and regulated like organs.

Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies.

Novel insight into glucagon receptor action: lessons from knockout and transgenic mouse models.

Estimating number and volume of islets transplanted within a planar immunobarrier diffusion chamber.

Rat neonatal beta cells lack the specialised metabolic phenotype of mature beta cells.

Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells.

First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.

Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.

Type 2 diabetes prevention across the life course.

Large-scale whole-genome sequencing reveals the landscape and health implications of de novo mutations.

The Role of IGF-1 and IL-10 in Childhood Stunting: Evidence From Indonesia.

Role of glucagon in metabolic diseases.

Are sustainable plant-based diets suitable for all? A nutrigenetic perspective.

Systematic Screening of Tryptophan Metabolism Identifies Site- and Microbiota-Dependent Signatures of Tryptophan Utilization in Experimental Colitis.

Therapeutic potential and research progress of microecological agents in kidney diseases.

Gut microbiota-immune crosstalk in childhood and adolescent obesity: mechanistic insights and therapeutic potential focused on short-chain fatty acids and emerging metabolites.

Related Experiment Videos

Implicating PARP and NAD+ depletion in type I diabetes

Related Concept Videos

Related Articles